GelSana Therapeutics
Pre-clinicalGelsana Therapeutics develops novel hydrogels to heal wounds faster with less inflammation.
Founded
2018
Focus
Drug DeliveryRegenerative Medicine
About
Gelsana Therapeutics develops novel hydrogels to heal wounds faster with less inflammation.
Funding History
2Total raised: $3M
Grant$500KNational Institutes of HealthMar 15, 2022
Seed$2.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile